Gaudio E - Search Results

1

HMGA1-pseudogene7 transgenic mice develop B cell lymphomas.

De Martino M, De Biase D, Forzati F, Credendino SC, Palma G, Barbieri A, Arra C, Paciello O, Gaudio E, Ponzoni M, De Vita G, Chieffi P, Bertoni F, Fusco A, Esposito F. De Martino M, et al. Among authors: gaudio e. Sci Rep. 2020 Apr 27;10(1):7057. doi: 10.1038/s41598-020-62974-0. Sci Rep. 2020. PMID: 32341372 Free PMC article.

2

Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis.

Trapasso F, Drusco A, Costinean S, Alder H, Aqeilan RI, Iuliano R, Gaudio E, Raso C, Zanesi N, Croce CM, Fusco A. Trapasso F, et al. Among authors: gaudio e. DNA Cell Biol. 2006 Jun;25(6):376-82. doi: 10.1089/dna.2006.25.376. DNA Cell Biol. 2006. PMID: 16792508

3

Protein tyrosine phosphatase PTPRJ is negatively regulated by microRNA-328.

Paduano F, Dattilo V, Narciso D, Bilotta A, Gaudio E, Menniti M, Agosti V, Palmieri C, Perrotti N, Fusco A, Trapasso F, Iuliano R. Paduano F, et al. Among authors: gaudio e. FEBS J. 2013 Jan;280(2):401-12. doi: 10.1111/j.1742-4658.2012.08624.x. Epub 2012 May 30. FEBS J. 2013. PMID: 22564856 Free article.

4

Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma.

Chilà R, Basana A, Lupi M, Guffanti F, Gaudio E, Rinaldi A, Cascione L, Restelli V, Tarantelli C, Bertoni F, Damia G, Carrassa L. Chilà R, et al. Among authors: gaudio e. Oncotarget. 2015 Feb 20;6(5):3394-408. doi: 10.18632/oncotarget.2583. Oncotarget. 2015. PMID: 25428911 Free PMC article.

5

The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs.

Boi M, Gaudio E, Bonetti P, Kwee I, Bernasconi E, Tarantelli C, Rinaldi A, Testoni M, Cascione L, Ponzoni M, Mensah AA, Stathis A, Stussi G, Riveiro ME, Herait P, Inghirami G, Cvitkovic E, Zucca E, Bertoni F. Boi M, et al. Among authors: gaudio e. Clin Cancer Res. 2015 Apr 1;21(7):1628-38. doi: 10.1158/1078-0432.CCR-14-1561. Epub 2015 Jan 26. Clin Cancer Res. 2015. PMID: 25623213

6

Novel HDAC inhibitors exhibit pre-clinical efficacy in lymphoma models and point to the importance of CDKN1A expression levels in mediating their anti-tumor response.

Mensah AA, Kwee I, Gaudio E, Rinaldi A, Ponzoni M, Cascione L, Fossati G, Stathis A, Zucca E, Caprini G, Bertoni F. Mensah AA, et al. Among authors: gaudio e. Oncotarget. 2015 Mar 10;6(7):5059-71. doi: 10.18632/oncotarget.3239. Oncotarget. 2015. PMID: 25671298 Free PMC article.

7

The R3 receptor-like protein tyrosine phosphatase subfamily inhibits insulin signalling by dephosphorylating the insulin receptor at specific sites.

Shintani T, Higashi S, Takeuchi Y, Gaudio E, Trapasso F, Fusco A, Noda M. Shintani T, et al. Among authors: gaudio e. J Biochem. 2015 Sep;158(3):235-43. doi: 10.1093/jb/mvv045. Epub 2015 Jun 10. J Biochem. 2015. PMID: 26063811

8

Combination of the MEK inhibitor pimasertib with BTK or PI3K-delta inhibitors is active in preclinical models of aggressive lymphomas.

Gaudio E, Tarantelli C, Kwee I, Barassi C, Bernasconi E, Rinaldi A, Ponzoni M, Cascione L, Targa A, Stathis A, Goodstal S, Zucca E, Bertoni F. Gaudio E, et al. Ann Oncol. 2016 Jun;27(6):1123-1128. doi: 10.1093/annonc/mdw131. Epub 2016 Mar 8. Ann Oncol. 2016. PMID: 26961147 Free article.

9

Assessment of the Antiproliferative Activity of a BET Bromodomain Inhibitor as Single Agent and in Combination in Non-Hodgkin Lymphoma Cell Lines.

Bernasconi E, Gaudio E, Kwee I, Bertoni F. Bernasconi E, et al. Among authors: gaudio e. Methods Mol Biol. 2016;1436:305-12. doi: 10.1007/978-1-4939-3667-0_20. Methods Mol Biol. 2016. PMID: 27246223

10

Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strong in vivo antitumor activity in lymphoma.

Gaudio E, Tarantelli C, Ponzoni M, Odore E, Rezai K, Bernasconi E, Cascione L, Rinaldi A, Stathis A, Riveiro E, Cvitkovic E, Zucca E, Bertoni F. Gaudio E, et al. Oncotarget. 2016 Sep 6;7(36):58142-58147. doi: 10.18632/oncotarget.10983. Oncotarget. 2016. PMID: 27494885 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

439 results

Search Page